EBAC 13D/13G Filings - European Biotech Acquisition Corp.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2023-02-14 11:32 am Purchase	2022-12-31	13G	European Biotech Acquisition Corp. EBAC	Glazer Capital, LLC	1,254,733 9.500%	1,254,733 (New Position)	Filing History
2023-02-13 4:04 pm Purchase	2022-12-31	13G	European Biotech Acquisition Corp. EBAC	Periscope Capital Inc.	776,797 5.880%	776,797 (New Position)	Filing History
2023-02-06 4:43 pm Sale	2022-12-31	13G	European Biotech Acquisition Corp. EBAC	Integrated Core Strategies (US) LLC	793,018 6.000%	-19,042 (-2.34%)	Filing History
2022-02-14 06:19 am Purchase	2021-12-31	13G	European Biotech Acquisition Corp. EBAC	Citadel Advisors LLC	625,909 4.700%	625,909 (New Position)	Filing History
2022-02-08 4:10 pm Purchase	2021-12-31	13G	European Biotech Acquisition Corp. EBACU	LSP Sponsor EBAC B.V.	3,593,792 21.920%	3,593,792 (New Position)	Filing History
2022-01-27 4:35 pm Purchase	2021-12-31	13G	European Biotech Acquisition Corp. EBAC	Integrated Core Strategies (US) LLC	812,060 6.100%	812,060 (New Position)	Filing History
2021-04-02 4:01 pm Purchase	2021-03-23	13G	European Biotech Acquisition Corp. EBACU	Citadel Advisors LLC	625,093 5.000%	625,093 (New Position)	Filing History
2021-03-24 4:13 pm Purchase	2021-03-16	13G	European Biotech Acquisition Corp. EBACU	Integrated Core Strategies (US) LLC	870,000 7.000%	870,000 (New Position)	Filing History